ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00655395
Recruitment Status : Unknown
Verified March 2010 by Weill Medical College of Cornell University.
Recruitment status was:  Active, not recruiting
First Posted : April 9, 2008
Last Update Posted : March 9, 2010
Sponsor:
Collaborator:
Vion Pharmaceuticals
Information provided by:
Weill Medical College of Cornell University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2010
  Estimated Study Completion Date : October 2010